During the past decade, interest in the monitoring of hypnotic depth during general anaesthesia has been increased. The measurement of the EEG-derived bispectral index BIS TM is a widely used assessment of the actual state of cerebral activity. 1 2 Alternatively, the measurement of auditory-evoked potentials (AEPs) offers fast detection of neuronal information processing in response to acoustic stimuli. AEP measurements correlate with hypnotic depth measured by EEG and thus have been proposed as a reliable method for the assessment of anaesthetic depth during general anaesthesia. 3 -7 In a recent study, however, we found the AEP measurements to indicate a decrease in hypnotic depth after 35 min exposure to xenon anaesthesia, although simultaneously acquired BIS values indicated adequate anaesthetic depth, and although AEP values for patients undergoing sevoflurane anaesthesia remained stable. 8 In the previous study, hypnotic depth was determined using the A-line autoregressive index (cAAI), which assesses the response to acoustic signals in the cerebral auditory cortex using an individual algorithm (AEP Monitor/2 TM , software version 2, Danmeter A/S). 9 Recently, a new AEP monitor has been introduced into clinical routine [auditory-evoked potential index (aepEX) monitor, Medical Device Management Ltd, Essex, UK] that measures hypnotic depth during general anaesthesia by the means of direct EEG-derived values. 10 11 The aepEX values are closely related to the AEP waveforms and calculated within 144 ms after an intermittent auditory stimulation via earphones. 12 -14 The validity of aepEX monitoring during general anaesthesia with xenon during induction, maintenance, and emergence of anaesthesia has so far not been systematically investigated. The aim of the present study was therefore to evaluate anaesthetic depth monitoring using aepEX during general anaesthesia with xenon.
Given the derivation of aepEX values from EEG signals, we hypothesized that aepEX provides an adequate monitoring of anaesthetic depth during balanced xenon anaesthesia, which should be comparable with BIS monitoring and with aepEX measurement obtained during general anaesthesia with sevoflurane.
Methods

Patients and study design
After approval by the local institutional review board and the German federal drug administration (BfArM) and after obtaining written informed consent, 42 patients undergoing elective abdominal surgery were enrolled. This mono-centre study was designed as a multifactorial, randomized, doubleblinded, controlled clinical trial and is in part presented here. The study was registered at the European Medicines Agency (EudraCT number: 2008-004132-20) and at ClinicalTrials.gov (NCT number: 00793663).
Patients were eligible, if they were classified as ASA I-III physical status category and were undergoing gynaecologic or urologic abdominal surgery. Baseline characteristics (age, sex, height, weight, and calculated BMI) were assessed and documented.
Exclusion criteria were severe cardiac, respiratory, liver, or kidney function failure, severe neurological dysfunctions, auditory problems, suspicion of malignant hyperthermia, and pregnancy. Patients enrolled in the trial were randomly assigned to one of the two study arms and blinded from receiving either sevoflurane or xenon.
Intervention
All patients received standardized anaesthesia and premedication according to our clinical standard. After admission to the operation theatre, the BIS (BIS VISTA TM monitor, software 2.00, Aspect Medical Systems//BIS Model A 2000 w , Software Version 2.21, Aspect Medical Systems, Boston, MA, USA) and aepEX monitoring (aepEX monitor, Medical Device Management Ltd) were initiated in accordance with the manufacturer's guidelines. The BIS probe was placed on the forehead of each patient. For aepEX, two disposable electrodes were positioned on the centreline of the forehead (ground electrode) and, nearby, to the same side (active electrode). The reference electrode was placed over the mastoid on the same side of the head as the active electrode. By transmitting a regular click sound via earphones at a nominal frequency of 7 Hz, binaurally auditory potentials are evoked. The detected AEPs are consecutively extracted from the raw EEG signal by the internal processor. The EEG signal reflects the brainstem auditory-evoked potential and the middle latency auditory-evoked potential (MLAEP), which are the response of the brain to the auditory stimulation. The aepEX values are closely related to the AEP waveforms and are calculated as the sum of square roots of the absolute difference between every two successive 0.56 ms segments of the AEP waveforms. Finally, the determined characteristics of the present waveforms are expressed as a calculated index varying between 0 (no brain activity) and 100 (wide awake). The recommended reference range for general anaesthesia is from 30 to 45. 12 BIS and AEP data were continuously recorded during the monitoring process, which was maintained from the time of arrival in the operation theatre until full recovery after end of anaesthesia. The performing attending anaesthetist was blinded to the BIS and aepEX values. After termination of anaesthesia, all recovery-related data were collected with the dependent BIS and aepEX values on the predefined time points: eye opening, reaction on demand, extubation, and full orientation. Subsequently, the observer's assessment of alertness/ sedation scale (OAA/S) was assessed. 15 min before the last suture. At the end of all surgical procedures, anaesthesia was terminated via high-flow 100% oxygen application, and remifentanil infusion was stopped aepEX monitor for the measurement of hypnotic depth as well. Tracheal extubation was performed when standard extubation criteria were fulfilled. After stopping anaesthesia, a physician, blinded to the choice of anaesthetic, continuously asked the patient to open the eyes, to squeeze the hand, and simultaneously assessed the patient's grade of sedation using the OAA/S scale in consecutive minutes, recording significant points of awakening. 15 The patients were observed in the operating theatre until full orientation and subsequently transported to the post-anaesthetic care unit (PACU) for further recovery. Nausea and pain were assessed with a 10-point numeric rating scale and treated according to our clinical standards. After further uneventful recovery, the patients were transferred to the standard care units. In order to assess intraoperative awareness in the form of recalls, the Brice questionnaire was performed at 2 and 12 h after end of anaesthesia by an independent physician. 16 
Statistical analysis
All data were statistically analysed using a commercially available software package (SPSS 19.0; SPSS Inc., Chicago, IL, USA).
As a primary endpoint, we evaluated the behaviour of the auditory-evoked potentials as assessed by the aepEX monitor in patients undergoing general anaesthesia with xenon. The aepEX-derived values were compared with BIS monitoring and, in addition, with a control group of patients undergoing general anaesthesia with sevoflurane.
Secondary endpoints were clinically relevant outcome and recovery parameters consisting of Aldrete and Myles score and the assessment of intraoperative awareness.
All data were tested for normal distribution using the Shapiro-Wilk W-test. Normally distributed results of single measurements were compared using Student's t-test. Proportions were compared using the x 2 test. In all cases, a level of P,0.05 was considered statistically significant. The power of the study was calculated with a one-sided test significance level, a¼0.05. The equivalence limit difference, d 0 , was assumed to be 10 and the expected difference, d 1 , was set to be 0. Our previous studies have shown a common standard deviation, s¼12. A power of 80% results in a sample size of 19 per group. For both groups, 21 patients were included to compensate for possible drop-outs. The power calculation was performed using nQuery Advisor w Version 7.0 (Statistical Solutions, Saugus, MA, USA).
Results
Preoperative evaluation
Forty-two patients were enrolled in this study and randomized to receive anaesthesia with either sevoflurane or xenon. One patient from the sevoflurane group was excluded because the surgical procedure was changed intraoperatively. In the xenon group, a surgical procedure was terminated prematurely because of acute intraoperative respiratory worsening that was presumably not due to xenon application (Fig. 1) .
Baseline characteristics of the patients are shown in Tables 1 and 2 . Patients did not differ with respect to their baseline characteristics and intraoperative data. Likewise, the past medical history of the patients, home medication, and preoperative evaluation regarding nausea and general wellbeing were similar between the groups (data not shown).
Duration of anaesthesia and the type of surgery were comparable between the groups. As shown in Table 2 , there was no significant difference with respect to the intra-and postoperative remifentanil and piritramide consumption.
Patients in the xenon group showed significantly higher arterial pressures in comparison with those in the sevoflurane group, while heart rate was similar between the groups (Fig. 2) . In comparison with the aepEX indices, the BIS values reacted analogously to surgical stimuli and during the emergence from anaesthesia (Fig. 2) . In the course of anaesthesia, mean BIS values were on the lower recommended reference range without differences between the anaesthetics. We 
Intraoperative aepEX monitoring
Postoperative recovery from anaesthesia
Patients in the xenon group showed a significantly faster recovery with respect to 'time to open eyes', 'time to react aepEX monitor for the measurement of hypnotic depth BJA on demand', 'time to extubation', and 'time to time orientation' (Table 3) . At the time points 'eye opening' and 'react on demand', BIS values showed significantly lower levels in the xenon group than in the sevoflurane group, whereas aepEX indices remained comparable with values from the sevoflurane group (Table 3) . The OAA/S score did not differ at the predefined time points. After clinical observation and postoperative Brice interview, no signs of awareness were recorded (Table 4) .
Discussion
We analysed the behaviour of the aepEX during balanced xenon anaesthesia. Intraoperative measurement of aepEX indices yielded a comparable behaviour with the BIS co-monitoring in patients undergoing anaesthesia with either xenon or sevoflurane.
Monitoring of anaesthetic depth has been extensively studied during the last decade, but no gold standard for the measurement of anaesthetic depth could be established yet. 17 -22 Particularly in patients undergoing xenon anaesthesia, the validity of the BIS monitoring remains controversial. with xenon, whereas during induction and emergence from anaesthesia, the recorded BIS values indicated a delayed reaction. These observations are in accordance with our findings. After achievement of steady-state conditions, BIS values remained within the recommended reference range and were comparable during xenon and sevoflurane anaesthesia. Moreover, clinical signs or haemodynamics did not reveal any hint of inadequate anaesthetic depth. During emergence from anaesthesia, we observed markedly lower BIS values in the xenon group than in the sevoflurane group at each corresponding time point (open eyes -react on demand -extubation-orientation) that did not correlate with the clinical evaluation. Moreover, the measured BIS values exhibited a considerable increase in variance during emergence from anaesthesia. Reasons for these observations during emergence remain speculative but may be attributed to the fact that BIS values represent the average of a preceding acquisition period of the previous 60 s. 25 Because of its unique pharmacokinetic profile, xenon offers a very rapid emergence from anaesthesia, so that changes in neuronal activity might occur too fast to be adequately followed by the BIS algorithm. Moreover, as an EEG-derived signal, BIS is subject to interference and artifact, particularly from EMG activity/eye movement, which occur sooner after xenon than sevoflurane anaesthesia. Furthermore, it has previously been suspected that xenon might affect the BIS values and cause affection of EEG values with reduction of its frequency. 23 As an alternative to BIS monitoring, other monitors of hypnotic depth, such as the measurement of AEPs, have been proposed. 26 In our previous study, we were, however, not able to demonstrate an adequate hypnotic depth measurement using the cAAI values during steady state and emergence from balanced xenon anaesthesia. 8 After the introduction of a new algorithm for the intraoperative assessment of AEPs, we investigated the validity of the aepEX monitoring during balanced xenon anaesthesia. During induction and the steady state of xenon anaesthesia, the aepEX monitoring exhibited a comparable behaviour with the established BIS monitoring. 27 Moreover, during xenon anaesthesia, both BIS and aepEX behaved similar to the results obtained in patients undergoing sevoflurane anaesthesia. In contrast to our previous findings with cAAI, we now did not observe an increase in aepEX indices during xenon anaesthesia. The reasons for this discrepancy might be due to the different measurement algorithms implemented in the cAAI and the aepEX device. The cAAI index is generated after an analysis window of 20-80 ms from a combination of the MLAEP and the EEG. Although higher concentrations of anaesthetics are provided, the MLAEP signal is reduced and the cAAI index is derived from spontaneous EEG. After the end of exposure to anaesthetics, the MLAEP signal becomes stronger again and index is generated from the MLAEP. 28 29 In contrast, the aepEX index is derived directly from the AEP in real time.
During the early course of anaesthesia, we several times observed significantly lower aepEX and BIS values in the xenon group, while neither the inspiratory gas concentration nor haemodynamic parameters showed major changes at these time points and although no additional bolus of propofol, larger doses of remifentanil, or an increase in inspiratory xenon concentration was administered to the patients in the xenon group that could have increased anaesthetic depth. Reasons for the significant difference between the groups are therefore speculative; one possibility could be a slight arousal caused by painful surgical stimuli.
In accordance with the results of previous studies, 8 30-32 patients in the xenon group showed significantly faster emergence from anaesthesia than those in the sevoflurane group. These findings underline the well known and favourable properties of xenon and show significant faster recovery time at each predefined time during the emergence. Today, there is a growing body of evidence, indicating that xenon anaesthesia is associated with better maintenance of arterial pressure and heart rate than volatile anaesthetics and propofol. 33 34 Our data are consistent with these findings and show that throughout the steady state of general anaesthesia. The level of systolic arterial pressure was significantly higher in the xenon group, while the mean heart rate did not increase. Notwithstanding, patients did not show any signs of intraoperative awareness or recalls during the postoperative follow-up and BIS and aepEX values during xenon anaesthesia were well within the published reference ranges for an adequate hypnotic depth during anaesthesia. These reference ranges have been validated for propofol and volatile anaesthetics. 10 11 35 36 However, recent observations from positron emission tomography have revealed that xenon anaesthesia results in a global and regional pattern of cortical neuronal depression that is very similar to that seen during anaesthesia with propofol or volatile anaesthetics. 37 -39 This may explain why anaesthetic depth monitors that rely on the procession of superficial cortical signals deliver valid information about level of sedation also during xenon anaesthesia. Considering the limitations of the present study, the lack of a gold standard for anaesthetic depth measurement might mitigate our conclusion. Although BIS monitoring has repeatedly been shown to provide reliable measurement of hypnotic depth, the validity of this monitoring remains controversial. 40 Therefore, we have to concede that aepEX monitoring does not necessarily reflect a true assessment of anaesthetic depth but can only state that hypnotic depth monitoring using aepEx was comparable with BIS measurement and clinical evaluation. Furthermore, we have to acknowledge that the study was only adequately powered for the assessment of anaesthetic depth. The evaluation of recovery parameters and intraoperative awareness was performed as safety measurements and therefore these results should be interpreted with caution. In addition, we admit that xenon anaesthesia is still not commonly used which could alleviate the present data.
In conclusion, we found the aepEX monitor to provide index in the range of adequate depth of xenon anaesthesia, when combined with remifentanil infusion in intubated patients undergoing elective abdominal surgery.
